Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Liquid Biopsy for Early Detection of Metastatic Melanoma

NCT06488365 is registered in ClinicalTrials.gov with Cytoastra as lead sponsor.

NCT NCT06488365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06488365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Liquid Biopsy for Early Detection of Metastatic Melanoma
Lead sponsor
Cytoastra
Phase
Not applicable
Overall status
Recruiting
Start date
February 11, 2025
Completion date
March 31, 2026
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cells, diagnosis, melanoma, metastatic melanoma